Latest in Licensing & Partnerships

140 words

Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities

Co-authored IND submission preparation study results demonstrate ~97% reduction in time to first draft and 60% overall timeline compression SAN FRANCISCO, September 01, 2026--(BUSINESS WIRE)--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced a collaboration with Takeda to…

Licensing & Partnerships

Licensing deals and collaborations between drugmakers and biotechs: rights to drug candidates, upfront payments and the wave of deals for Chinese biotech assets.

  • 68 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

  • +28 more